Table 3. Characteristics of the study subjects (2014).
| All (N = 29,344) |
Category I (N = 4,213) |
Category II (N = 12,911) |
Category III (N = 10,038) |
Secondary prevention (N = 2,182) |
|
|---|---|---|---|---|---|
| Age (yr) | 64.5 ± 8.5 | 49.9 ± 6.1 | 67.6 ± 4.5 | 66.0 ± 7.5 | 68.3 ± 5.6 |
| Male (%) | 10,132 (34.5) | 742 (17.6) | 3,627 (28.1) | 4,619 (46.1) | 1,144 (52.4) |
| Body mass index (kg/m2) | 22.7 ± 3.4 | 21.9 ± 3.5 | 22.4 ± 3.1 | 23.4 ± 3.6 | 23.4 ± 3.5 |
| Waist circumference (cm) | 82.6 ± 9.6 | 78.9 ± 9.6 | 81.9 ± 9.0 | 84.5 ± 9.9 | 84.9 ± 9.8 |
| Total cholesterol (mg/dl) | 201.5 ± 34.1 | 202.3 ± 33.9 | 204.1 ± 33.0 | 200.8 ± 35.0 | 190.3 ± 33.0 |
| Triglyceride (mg/dl) | 120.0 ± 80.7 | 103.3 ± 69.3 | 115.3 ± 68.9 | 131.3 ± 92.5 | 128.1 ± 99.6 |
| HDL cholesterol (mg/dl) | 62.2 ± 15.7 | 67.6 ± 15.3 | 63.8 ± 14.7 | 58.7 ± 16.0 | 58.1 ± 16.0 |
| LDL cholesterol (mg/dl) | 122.0 ± 30.8 | 120.5 ± 31.3 | 124.3 ± 29.6 | 121.6 ± 31.9 | 113.1 ± 29.9 |
| Smoking (%) | 3,616 (12.3) | 618 (14.7) | 1,279 (9.9) | 1,460 (14.5) | 259 (11.9) |
| Suspected CKD (%) | 7,486 (25.5) | 0 (0) | 0 (0) | 6,681 (66.6) | 805 (36.9) |
| Stroke (%) | 1,396 (4.8) | 0 (0) | 0 (0) | 1,104 (11.0) | 292 (13.4) |
| Coronary artery disease (%) | 2,182 (7.4) | 0 (0) | 0 (0) | 0 (0) | 2,182 (100) |
| Hypertension (%) | 10,047 (34.2) | 438 (10.4) | 4,221 (32.7) | 4,198 (41.8) | 1,190 (54.5) |
| Diabetes (%) | 2,812 (9.6) | 0 (0) | 0 (0) | 2,443 (24.3) | 369 (16.9) |
| Lipid-lowering therapy (%) | 7,163 (24.4) | 358 (8.5) | 3,431 (26.6) | 2,680 (26.7) | 694 (31.8) |
| Hypertriglyceridemia (%) | 6,662 (22.7) | 672 (15.9) | 2,575 (19.9) | 2,828 (28.2) | 587 (26.9) |
| Low HDL cholesterolemia (%) | 1,462 (5.0) | 0 (0) | 115 (0.9) | 1,129 (11.2) | 218 (10.0) |
| Hypertriglyceridemia and low HDL cholesterolemia (%) | 930 (3.2) | 0 (0) | 83 (0.6) | 724 (7.2) | 123 (9.6) |
CKD: Chronic kidney disease, Hypertriglyceridemia was defined as triglyceride ≥ 150 mg/dl. Low HDL cholesterolemia was defined as HDL cholesterol <40 mg/dl